Rachel Frank | executive |
Sanj Patel | executive |
Ross Moat | executive |
Mark Ragosa | executive |
Anupam Rama | analyst |
Kyuwon Choi | analyst |
Alexandria Hammond | analyst |
John Paolini | executive |
David Nierengarten | analyst |
Liisa Bayko | analyst |
Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Rachel Frank, Head of Investor Relations.
Thank you, operator.